KU Hematology & Medical Oncology Review 2019

 

Skin
12:46

KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Update on Surgical Treatment of Melanoma & Adjuvant Ipilimumab in High-Risk Melanoma

FEATURING Gary Doolittle
  • 68 views
  • August 22, 2019
07:50

KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Updates on Trial Discussing Nivolumab + Ipilimumab in Melanoma Brain Metastases

FEATURING Gary Doolittle
  • 258 views
  • August 22, 2019
08:44

KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Long-Term Survival of Dabrafenib Plus Trametinib in Metastic BRAF-Mutated Melanoma & PR and Survival of Neoadjuvant Therapy

FEATURING Gary Doolittle
  • 240 views
  • August 22, 2019